Connection

BETH CHASEN to Delayed-Action Preparations

This is a "connection" page, showing publications BETH CHASEN has written about Delayed-Action Preparations.
Connection Strength

0.035
  1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 01 12; 376(2):125-135.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.